XML 104 R89.htm IDEA: XBRL DOCUMENT v3.20.2
SHAREHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance     $ 29,861  
Other comprehensive income (loss) $ 695 $ 1,433 2,241 $ 3,010
Ending balance [1] 34,793 29,153 34,793 29,153
Adjustments to investment securities before reclassifications (420) (877) (1,382) (2,888)
Accumulated other comprehensive income (loss)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance (10,194) (12,852) (11,732) (14,414)
Ending balance (9,498) (11,361) (9,498) (11,361)
Investment securities including noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance 47 59 61 (39)
Other comprehensive income (loss) before reclassifications 3 30 44 151
Other comprehensive income (loss) before reclassifications, deferred taxes 0 15 7 30
Reclassifications from other comprehensive income 5 (12) (50) (35)
Reclassifications from other comprehensive income, deferred taxes 2 (3) (12) (9)
Other comprehensive income (loss) 9 18 (5) 116
Investment securities attributable to noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 0 0 0 0
Investment securities        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 9 18 (5) 116
Ending balance 55 77 55 77
Currency translation adjustments including noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance (4,743) (5,874) (4,818) (6,134)
Other comprehensive income (loss) before reclassifications 55 (189) (558) (191)
Other comprehensive income (loss) before reclassifications, deferred taxes (59) (12) (39) 27
Reclassifications from other comprehensive income 0 951 691 1,234
Reclassifications from other comprehensive income, deferred taxes 0 (5) 0 (9)
Other comprehensive income (loss) 55 762 133 1,043
Currency translation adjustments attributable to noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 0 (63) 3 (41)
Currency translation adjustments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 55 824 129 1,084
Ending balance (4,689) (5,050) (4,689) (5,050)
Cash flow hedges including noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance (109) 26 49 13
Other comprehensive income (loss) before reclassifications 62 (30) (160) (43)
Other comprehensive income (loss) before reclassifications, deferred taxes 62 (4) (7) (1)
Reclassifications from other comprehensive income (38) 28 26 56
Reclassifications from other comprehensive income, deferred taxes (13) 6 (5) 7
Other comprehensive income (loss) 24 (2) (134) 13
Cash flow hedges attributable to noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 0 1 0 2
Cash flow hedges        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 24 (2) (134) 11
Ending balance (86) 24 (86) 24
Benefit plans including noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Beginning balance (5,387) (7,063) (7,024) (8,254)
Other comprehensive income (loss) before reclassifications (87) 39 58 (72)
Other comprehensive income (loss) before reclassifications, deferred taxes (22) 1 6 36
Reclassifications from other comprehensive income 695 616 2,190 1,910
Reclassifications from other comprehensive income, deferred taxes 187 170 613 517
Other comprehensive income (loss) 609 655 2,248 1,838
Benefit plans attributable to noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 0 4 3 (4)
Benefit plans        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Other comprehensive income (loss) 609 650 2,245 1,842
Ending balance $ (4,779) $ (6,412) (4,779) $ (6,412)
BioPharma | Benefit plans including noncontrolling interests        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax        
Reclassifications from other comprehensive income     (836)  
Currency translation, net of taxes     $ 688  
[1] Total equity balance increased by $5,639 in the last twelve months from September 30, 2019, primarily due to after-tax gain of $11,214 million due to the sale of our BioPharma business within our Healthcare segment, partially offset by after-tax change in unrealized loss on our remaining interest in Baker Hughes $(3,679) million in the nine months ended September 30, 2020. See Notes 2 and 21 for further information.